ArticleCancer cell2015

Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2.

Eric F Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.